ID: ALA5206361

Max Phase: Preclinical

Molecular Formula: C52H73F3N8O11S

Molecular Weight: 1075.26

Associated Items:

Representations

Canonical SMILES:  CCCN(CCCCOCCOCCOCCOCCOCC(=O)N[C@@H](C(=O)N1C[C@@H](O)C[C@@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C)C[C@@H](C)NC(=O)c1ccc(-c2noc(C(F)(F)F)n2)cc1

Standard InChI:  InChI=1S/C52H73F3N8O11S/c1-7-18-62(31-35(2)58-47(66)40-16-14-39(15-17-40)46-60-50(74-61-46)52(53,54)55)19-8-9-20-69-21-22-70-23-24-71-25-26-72-27-28-73-33-43(65)59-45(51(4,5)6)49(68)63-32-41(64)29-42(63)48(67)56-30-37-10-12-38(13-11-37)44-36(3)57-34-75-44/h10-17,34-35,41-42,45,64H,7-9,18-33H2,1-6H3,(H,56,67)(H,58,66)(H,59,65)/t35-,41+,42-,45+/m1/s1

Standard InChI Key:  KBDZFZJFGKYVBZ-RBILXPFJSA-N

Associated Targets(Human)

Histone deacetylase 4 2328 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Histone deacetylase 5 941 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Histone deacetylase 7 1047 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Histone deacetylase 9 708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Class 1 histone deacetylase 459 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/Histone deacetylase 4 28 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1075.26Molecular Weight (Monoisotopic): 1074.5072AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Macabuag N, Esmieu W, Breccia P, Jarvis R, Blackaby W, Lazari O, Urbonas L, Eznarriaga M, Williams R, Strijbosch A, Van de Bospoort R, Matthews K, Clissold C, Ladduwahetty T, Vater H, Heaphy P, Stafford DG, Wang HJ, Mangette JE, McAllister G, Beaumont V, Vogt TF, Wilkinson HA, Doherty EM, Dominguez C..  (2022)  Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington's Disease Pathology.,  65  (18.0): [PMID:36098485] [10.1021/acs.jmedchem.2c01149]

Source